Heather Ann McSharry sold $607k of JAZZ
director at Jazz Pharmaceuticals plc. 3,415 shares at an average of $177.78, traded Nov 20, 2025, filed Nov 24, 2025.
Score components
- +15RoleDirector
- +19Trade size$607k at market
- +5Share of holdings soldSold 14% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001576068-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | MOption exercise Ordinary Shares | +3,415 | $138.08 | $472k | 23,864 | Nov 24, 2025 |
| Nov 20, 2025 | SOpen-market sale Ordinary Shares | -3,415 | $177.78 | $607k | 20,449 | Nov 24, 2025 |
| Nov 20, 2025 | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -3,415 | $0.00 | $0 | 0 | Nov 24, 2025 |
Related signals
Other insiders at Jazz Pharmaceuticals plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $473k 2,000 shares | -1% | |
| 28Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.4M 6,000 shares | -2% | |
| 24Weak | Jazz Pharmaceuticals plc | Neena M Patil EVP & Chief Legal Officer | $289k 1,200 shares | -2% | |
| 38Weak | Jazz Pharmaceuticals plc | Renee D Gala President & CEO | $486k 2,000 shares | -1% | |
| 45Moderate | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.5M 6,000 shares | -2% | |
| 41Moderate | Jazz Pharmaceuticals plc | Patricia Carr SVP, Chief Accounting Officer | $235k 1,287 shares | -17% | |
| 28Weak | Jazz Pharmaceuticals plc | Bruce C Cozadd Chairman & CEO | $1.1M 6,000 shares | -1% | |
| 45Moderate | Jazz Pharmaceuticals plc | Patricia Carr SVP, Chief Accounting Officer | $456k 2,370 shares | -20% | |
| 51Moderate | Jazz Pharmaceuticals plc | Mary Elizabeth Henderson SVP, Technical Operations | $379k 2,238 shares | -10% | |
| 57Moderate | Jazz Pharmaceuticals plc | Patricia Carr SVP, Chief Accounting Officer | $798k 4,660 shares | -65% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.